DK154749C - PROCEDURE FOR PREPARING AN INFLUENZA VIRUS VACCINE IN A LIQUID CELL CULTURE - Google Patents

PROCEDURE FOR PREPARING AN INFLUENZA VIRUS VACCINE IN A LIQUID CELL CULTURE

Info

Publication number
DK154749C
DK154749C DK212580A DK212580A DK154749C DK 154749 C DK154749 C DK 154749C DK 212580 A DK212580 A DK 212580A DK 212580 A DK212580 A DK 212580A DK 154749 C DK154749 C DK 154749C
Authority
DK
Denmark
Prior art keywords
preparing
procedure
cell culture
influenza virus
virus vaccine
Prior art date
Application number
DK212580A
Other languages
Danish (da)
Other versions
DK212580A (en
DK154749B (en
Inventor
Karen K Brown
Richard C Stewart
Original Assignee
Mobay Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK154749(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mobay Corp filed Critical Mobay Corp
Publication of DK212580A publication Critical patent/DK212580A/en
Publication of DK154749B publication Critical patent/DK154749B/en
Application granted granted Critical
Publication of DK154749C publication Critical patent/DK154749C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK212580A 1979-05-15 1980-05-14 PROCEDURE FOR PREPARING AN INFLUENZA VIRUS VACCINE IN A LIQUID CELL CULTURE DK154749C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15
US3923679 1979-05-15

Publications (3)

Publication Number Publication Date
DK212580A DK212580A (en) 1980-11-16
DK154749B DK154749B (en) 1988-12-19
DK154749C true DK154749C (en) 1989-05-16

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK212580A DK154749C (en) 1979-05-15 1980-05-14 PROCEDURE FOR PREPARING AN INFLUENZA VIRUS VACCINE IN A LIQUID CELL CULTURE

Country Status (13)

Country Link
EP (1) EP0019218B2 (en)
JP (1) JPS55153723A (en)
AR (1) AR220838A1 (en)
AT (1) ATE16454T1 (en)
AU (1) AU535804B2 (en)
CA (1) CA1122527A (en)
DE (1) DE3071225D1 (en)
DK (1) DK154749C (en)
ES (1) ES8104405A1 (en)
IL (1) IL60063A0 (en)
NO (1) NO801443L (en)
RO (1) RO79525B (en)
YU (1) YU41923B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
DE69535940D1 (en) * 1994-11-10 2009-06-04 Baxter Healthcare Sa Process for the production of biological products in protein-free culture
JPH11509081A (en) * 1994-11-16 1999-08-17 セント ジュード チルドレンズ リサーチ ホスピタル New replication process
DE19612967A1 (en) * 1996-04-01 1997-10-02 Behringwerke Ag Process for the propagation of influenza viruses in cell culture, and the influenza viruses obtainable by the process
DE19612966B4 (en) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK cells and methods of propagating influenza viruses
DE10144906B4 (en) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Process for the large-scale production of vaccines
US6830917B2 (en) * 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
EP2923711A1 (en) 2004-11-03 2015-09-30 Novartis Vaccines and Diagnostics, Inc. Influenza vaccination
EP2022849A4 (en) * 2006-05-11 2010-10-06 Chemo Sero Therapeut Res Inst Method for proliferation of influenza virus
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
EA201500910A1 (en) 2009-02-10 2016-04-29 Новартис Аг VACCINES AGAINST FLU WITH REDUCED NUMBER OF SQUALES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (en) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
YU126580A (en) 1983-12-31
IL60063A0 (en) 1980-07-31
RO79525A (en) 1984-07-17
ES491517A0 (en) 1981-04-01
NO801443L (en) 1980-11-17
DK212580A (en) 1980-11-16
YU41923B (en) 1988-02-29
EP0019218B2 (en) 1995-03-01
CA1122527A (en) 1982-04-27
RO79525B (en) 1984-09-30
EP0019218A3 (en) 1981-03-25
DK154749B (en) 1988-12-19
JPS55153723A (en) 1980-11-29
DE3071225D1 (en) 1985-12-19
ATE16454T1 (en) 1985-11-15
JPH0124769B2 (en) 1989-05-15
AR220838A1 (en) 1980-11-28
AU5824480A (en) 1980-11-20
EP0019218B1 (en) 1985-11-13
ES8104405A1 (en) 1981-04-01
EP0019218A2 (en) 1980-11-26
AU535804B2 (en) 1984-04-05

Similar Documents

Publication Publication Date Title
DK154539C (en) PROCEDURE FOR PREPARING CYCLOSPOR-CONTAINING PHARMACEUTICAL PREPARATIONS IN LIQUID FORM
DK149942C (en) PROCEDURE FOR PREPARING A PASTEURELLOSE VACCINE
DK154749C (en) PROCEDURE FOR PREPARING AN INFLUENZA VIRUS VACCINE IN A LIQUID CELL CULTURE
DK223976A (en) CELL CULTURE PROCEDURE
DK54879A (en) PROCEDURE FOR PREPARING PYRIMIDONES
DK363179A (en) PROCEDURE FOR PREPARING TETRAZOLYLALCOXYCARBOSTYRIC DERIVATIVES
DK457779A (en) PROCEDURE FOR PREPARING 4-HYDROXY-2-PYRONE DERIVATIVES
DK159100C (en) PROCEDURE FOR PREPARING A LIQUID VIRAL VACCINE CONTAINING A STABILIZER AND STABILIZER THAT CAN BE USED IN SUCH A PROCEDURE
DK19579A (en) PROCEDURE FOR PREPARING SPIROTHIENH HYDANTO INTERVENTIVES
DK7579A (en) PROCEDURE FOR PREPARING (% N-DIETHYLMETA-TOLUAMIDE
DK488379A (en) PROCEDURE FOR PREPARING POLYETHERIC DERIVATIVES
DK409780A (en) PROCEDURE FOR PREPARING PEPTIDES
DK155915C (en) PROCEDURE FOR PREPARING PERTUSSIS TOXOID FOR USE IN VACCINES
DK455679A (en) PROCEDURE FOR PREPARING RECOMBINATE DNA.
DK294880A (en) PROCEDURE FOR PREPARING N-PHOSPHONOMETHYLGYLINE
DK580378A (en) SHEET WITH HIGH CONTAINER FILLING AND PROCEDURE FOR THEIR PREPARATION
DK148981C (en) PROCEDURE FOR PREPARING AN IMMOBILIZED ENZYME PREPARATION
DK143477A (en) CELL CULTURE PROCEDURE
DK289378A (en) VIRUS CULTURE PROCEDURE
DK7679A (en) PROCEDURE FOR PREPARING A PROSTAGLAND-CONTAINING PREPARATION
DK517979A (en) PROCEDURE FOR PREPARING ALCOHOL
DK307080A (en) PROCEDURE FOR PREPARING A NEW POLYVALENT VIRUS VACCINE
DK330279A (en) PROCEDURE FOR PREPARING SOEM
DK177680A (en) PROCEDURE FOR PREPARING 7-N-HETEROCYCLYL-CEPHALOSPORINES
DK569078A (en) PROCEDURE FOR PREPARING NEW ARYLAMINOIMIDAZOLINE DERIVATIVES

Legal Events

Date Code Title Description
PUP Patent expired